$CVSI
CV Sciences, Inc. Stock $cvsi

$cvsi Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000151096421000012 Filed on March 19, 2021

Income Statement

Concept	2020 Q4	2019 Q4	2019
Revenue	$5.199M	$9.328M	$53.70M
YoY Change	-44.26%	-34.42%	11.3%
Cost Of Revenue	$2.978M	$5.178M	$18.61M
YoY Change	-42.49%	5.39%	29.53%
Gross Profit	$2.221M	$4.150M	$35.09M
YoY Change	-46.48%	-55.43%	3.57%
Gross Profit Margin	42.72%	44.49%	65.35%
Selling, General & Admin	$11.41M	$10.19M	$46.45M
YoY Change	11.96%	75.86%	113.61%
% of Gross Profit	513.69%	245.54%	132.38%
Research & Development		$1.303M	$5.877M
YoY Change		71.51%	211.78%
% of Gross Profit		31.4%	16.75%
Depreciation & Amortization	$243.0K	$183.0K	$716.0K
YoY Change	32.79%	27.68%	37.96%
% of Gross Profit	10.94%	4.41%	2.04%
Operating Expenses	$11.69M	$11.49M	$52.33M
YoY Change	1.67%	75.35%	121.44%
Operating Profit	-$9.464M	-$7.343M	-$17.24M
YoY Change	28.88%	-366.4%	-268.24%
Interest Expense	-$9.000K	$13.00K	$15.00K
YoY Change	-169.23%	-598.08%	-90.2%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$9.473M	-$7.330M	-$17.23M
YoY Change	29.24%	-366.18%	-270.65%
Income Tax	-$179.0K	-$644.0K	-$615.0K
% Of Pretax Income
Net Earnings	-$9.294M	-$6.686M	-$16.61M
YoY Change	39.01%	-330.49%	-266.08%
Net Earnings / Revenue	-178.77%	-71.68%	-30.93%
Basic Earnings Per Share			-$0.17
Diluted Earnings Per Share	-$92.79K	-$67.62K	-$0.17
COMMON SHARES
Basic Shares Outstanding	100.0M shares	99.30M shares	97.86M shares
Diluted Shares Outstanding			97.86M shares

Balance Sheet

Concept	2020 Q4	2019 Q4	2019
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.024M	$9.107M	$9.107M
YoY Change	-55.81%	-28.2%	-28.2%
Cash & Equivalents	$4.024M	$9.107M	$9.107M
Short-Term Investments
Other Short-Term Assets	$2.873M	$11.11M	$11.11M
YoY Change	-74.15%	1799.49%	381.04%
Inventory	$8.840M	$9.971M	$9.971M
Prepaid Expenses	$2.372M	$10.61M
Receivables	$1.126M	$2.177M	$2.177M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$16.86M	$32.37M	$32.37M
YoY Change	-47.9%	27.1%	27.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.877M	$3.615M	$12.32M
YoY Change	-20.41%	27.11%	333.33%
Goodwill	$2.788M	$2.788M
YoY Change	0.0%	0.0%
Intangibles	$3.730M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.310M	$1.442M	$1.442M
YoY Change	-9.15%	146.5%	-28.01%
Total Long-Term Assets	$13.76M	$20.32M	$20.32M
YoY Change	-32.27%	77.68%	77.68%
TOTAL ASSETS
Total Short-Term Assets	$16.86M	$32.37M	$32.37M
Total Long-Term Assets	$13.76M	$20.32M	$20.32M
Total Assets	$30.63M	$52.69M	$52.69M
YoY Change	-41.87%	42.78%	42.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.677M	$1.617M	$1.617M
YoY Change	3.71%	29.88%	29.88%
Accrued Expenses	$9.805M	$10.86M	$11.58M
YoY Change	-9.68%	306.14%	333.18%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Long-Term Debt Due	$2.174M
YoY Change
Total Short-Term Liabilities	$14.34M	$13.20M	$13.20M
YoY Change	8.64%	200.46%	200.46%
LONG-TERM LIABILITIES
Long-Term Debt	$1.453M	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$406.0K	$9.923M
YoY Change	-100.0%		646.65%
Total Long-Term Liabilities	$1.453M	$406.0K	$9.923M
YoY Change	257.88%		646.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.34M	$13.20M	$13.20M
Total Long-Term Liabilities	$1.453M	$406.0K	$9.923M
Total Liabilities	$19.41M	$23.54M	$23.54M
YoY Change	-17.53%	246.89%	246.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$63.92M	-$41.64M
YoY Change	53.52%	66.37%
Common Stock	$10.00K	$10.00K
YoY Change	0.0%	11.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.21M	$29.15M	$29.15M
YoY Change
Total Liabilities & Shareholders Equity	$30.63M	$52.69M	$52.69M
YoY Change	-41.87%	42.78%	42.78%

Cashflow Statement

Concept	2020 Q4	2019 Q4	2019
OPERATING ACTIVITIES
Net Income	-$9.294M	-$6.686M	-$16.61M
YoY Change	39.01%	-330.49%	-266.08%
Depreciation, Depletion And Amortization	$243.0K	$183.0K	$716.0K
YoY Change	32.79%	27.68%	37.96%
Cash From Operating Activities	-$1.468M	-$4.626M	-$2.227M
YoY Change	-68.27%	-275.68%	-117.73%
INVESTING ACTIVITIES
Capital Expenditures	-$263.0K	-$246.0K	$1.147M
YoY Change	6.91%	-69.99%	28.44%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$263.0K	-$246.0K	-$1.147M
YoY Change	6.91%	-69.99%	-7.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	192.0K	242.0K	$47.00K
YoY Change	-20.66%	117.92%	-104.01%
NET CHANGE
Cash From Operating Activities	-1.468M	-4.626M	-$2.227M
Cash From Investing Activities	-263.0K	-246.0K	-$1.147M
Cash From Financing Activities	192.0K	242.0K	$47.00K
Net Change In Cash	-1.539M	-4.630M	-$3.327M
YoY Change	-66.76%	-340.57%	-132.8%
FREE CASH FLOW
Cash From Operating Activities	-$1.468M	-$4.626M	-$2.227M
Capital Expenditures	-$263.0K	-$246.0K	$1.147M
Free Cash Flow	-$1.205M	-$4.380M	-$3.374M
YoY Change	-72.49%	-226.85%	-128.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001510964
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	us-gaap:ProductMember
CY2019	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	us-gaap:ProductMember
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y19D
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	000-54677
CY2020	dei	Entity Registrant Name EntityRegistrantName	CV Sciences, Inc.
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	80-0944974
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	10070 Barnes Canyon Road
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92121
CY2020	dei	City Area Code CityAreaCode	866
CY2020	dei	Local Phone Number LocalPhoneNumber	290-2157
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	true
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Public Float EntityPublicFloat	60000000	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	106605784	shares
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4024000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9107000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	501000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	501000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1126000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2177000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	8840000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	9971000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2372000	USD
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	10611000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	16863000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	32367000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2877000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3615000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3057000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8709000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3730000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3766000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	2788000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	2788000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1310000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1442000	USD
CY2020Q4	us-gaap	Assets Assets	30625000	USD
CY2019Q4	us-gaap	Assets Assets	52687000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1677000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1617000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9805000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10856000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	680000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	723000	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2174000	USD
CY2019Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14336000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13196000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3467000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9517000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1453000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	0	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	157000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	421000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	406000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	19413000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	23540000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	190000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	190000000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	100664000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	100664000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99416000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99416000	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	10000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	10000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	75123000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	70774000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63921000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41637000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11212000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	29147000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30625000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52687000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24429000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	53696000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	13420000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	18608000	USD
CY2020	us-gaap	Gross Profit GrossProfit	11009000	USD
CY2019	us-gaap	Gross Profit GrossProfit	35088000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2943000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5877000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	30658000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	46451000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	33601000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	52328000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-22592000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-17240000	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9000	USD
CY2019	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	15000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22601000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17225000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-317000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-615000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-22284000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-16610000	USD
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	99913000	shares
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	97861000	shares
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.22
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	30116000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	521000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5589000	USD
CY2019	cvsi	Adjustmentsto Additional Paidin Capital Sharebased Compensation Employment Settlement AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement	9531000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-16610000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	29147000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	175000	USD
CY2020	cvsi	Stock Issued During Period Value Equity Commitment StockIssuedDuringPeriodValueEquityCommitment	293000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3881000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-22284000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11212000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-22284000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-16610000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	872000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	716000	USD
CY2020	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	100000	USD
CY2019	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	3881000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	5589000	USD
CY2020	us-gaap	Royalty Expense RoyaltyExpense	0	USD
CY2019	us-gaap	Royalty Expense RoyaltyExpense	9531000	USD
CY2020	cvsi	Impairment Of Tax Receivable For Rsu Settlement ImpairmentOfTaxReceivableForRSUSettlement	6229000	USD
CY2019	cvsi	Impairment Of Tax Receivable For Rsu Settlement ImpairmentOfTaxReceivableForRSUSettlement	0	USD
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-191000	USD
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	133000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	236000	USD
CY2020	cvsi	Noncash Lease Expense NoncashLeaseExpense	598000	USD
CY2019	cvsi	Noncash Lease Expense NoncashLeaseExpense	817000	USD
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	264000	USD
CY2019	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	644000	USD
CY2020	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	134000	USD
CY2019	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-918000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-927000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1703000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1421000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2959000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3016000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2470000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1648000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7300000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2227000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1057000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1147000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1057000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1147000	USD
CY2020	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable	2906000	USD
CY2019	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable	0	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	474000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	193000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	175000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	521000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3274000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	47000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5083000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3327000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9608000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12935000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4525000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9608000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	9000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	20000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	99000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	15000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	89000	USD
CY2020	cvsi	Right Of Use Asset Foregone In Exchange For Reduction In Operating Lease Liability RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability	4704000	USD
CY2019	cvsi	Right Of Use Asset Foregone In Exchange For Reduction In Operating Lease Liability RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability	0	USD
CY2020	cvsi	Sale Of Property And Equipment In Exchange For Prepaid Expenses And Other And Inventory SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory	675000	USD
CY2019	cvsi	Sale Of Property And Equipment In Exchange For Prepaid Expenses And Other And Inventory SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory	0	USD
CY2020	cvsi	Purchase Of Insurance Through Issuance Of Note Payable PurchaseOfInsuranceThroughIssuanceOfNotePayable	721000	USD
CY2019	cvsi	Purchase Of Insurance Through Issuance Of Note Payable PurchaseOfInsuranceThroughIssuanceOfNotePayable	0	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5405000	USD
CY2020	cvsi	Recognitionof Equity Awardand Withholding Obligationand Receivable RecognitionofEquityAwardandWithholdingObligationandReceivable	0	USD
CY2019	cvsi	Recognitionof Equity Awardand Withholding Obligationand Receivable RecognitionofEquityAwardandWithholdingObligationandReceivable	6409000	USD
CY2020	cvsi	Cashless Exercise Of Stock Options CashlessExerciseOfStockOptions	108000	USD
CY2019	cvsi	Cashless Exercise Of Stock Options CashlessExerciseOfStockOptions	39000	USD
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results may differ from these estimates. Significant estimates include the valuation of intangible assets, inputs for valuing equity awards, and assumptions related to revenue recognition.</span>
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – As of December 31, 2020, the Federal Deposit Insurance Corporation (“FDIC”) provided insurance coverage of up to $0.3 million per depositor per bank. The Company has not experienced any losses in such accounts and does not believe that the Company is exposed to significant risks from excess deposits. The Company’s cash balance in excess of FDIC limits totaled $3.3 million as of December 31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company's raw materials purchases for the year ended December 31, 2019 were sourced from one supplier in Europe. During the year ended December 31, 2020 the Company added one additional domestic supplier. There was no concentration of accounts receivable or revenue as of and for the years ended December 31, 2020 and 2019.</span></div>
CY2020Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	3300000	USD
CY2020Q2	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable	2900000	USD
CY2020Q4	us-gaap	Cash Cash	1600000	USD
CY2020Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2400000	USD
CY2019Q4	us-gaap	Cash Cash	5100000	USD
CY2019Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	4000000.0	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4024000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9107000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	501000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	501000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4525000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9608000	USD
CY2020	cvsi	Accounts Receivable Thresholdfor Determining Delinquent Account AccountsReceivableThresholdforDeterminingDelinquentAccount	P30D
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	600000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	400000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24429000	USD
CY2020	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	53696000	USD
CY2019	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	100000	USD
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	200000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	1300000	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	2500000	USD
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4923000	USD
CY2019Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4503000	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	785000	USD
CY2019Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	415000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3132000	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	5053000	USD
CY2020Q4	us-gaap	Inventory Gross InventoryGross	8840000	USD
CY2019Q4	us-gaap	Inventory Gross InventoryGross	9971000	USD
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	300000	USD
CY2019Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	200000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5269000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5170000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2392000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1555000	USD
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2700000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2877000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3615000	USD
CY2020	us-gaap	Depreciation Depreciation	800000	USD
CY2019	us-gaap	Depreciation Depreciation	700000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3907000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	177000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3730000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3907000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	141000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3766000	USD
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	36000	USD
CY2019	us-gaap	Adjustment For Amortization AdjustmentForAmortization	35000	USD
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	0	USD
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	8324000	USD
CY2019Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	8787000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1481000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2069000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9805000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10856000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3627000	USD
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2174000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1453000	USD
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2174000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1453000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3627000	USD
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	190000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	190000000	shares
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	100664000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	100664000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99416000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99416000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y3M18D
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4300000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.329
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.261
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.005
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.016
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y3M29D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y8M26D
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.36
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.92
	cvsi	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Peers Includedin Calculationof Expected Volatility SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility	5	company
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.065
CY2020	us-gaap	Revenues Revenues	24429000	USD
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	25225000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28105000	shares
CY2020Q4	cvsi	Accrued Payroll Taxes Current Employee Portion AccruedPayrollTaxesCurrentEmployeePortion	200000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3100000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4100000	USD
CY2020	us-gaap	Lease Cost LeaseCost	1000000.0	USD
CY2019	us-gaap	Lease Cost LeaseCost	1500000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	1100000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	928000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	925000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	957000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	986000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive	1015000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	85000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4896000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	749000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4147000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	680000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3467000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4147000	USD
CY2020	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2020	us-gaap	Gross Profit GrossProfit	11009000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2943000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	30658000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-22592000	USD
CY2019	us-gaap	Revenues Revenues	53696000	USD
CY2019	us-gaap	Gross Profit GrossProfit	35088000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5877000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	46451000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-17240000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-52000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	29000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-52000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	29000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-640000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-264000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-265000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-644000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-317000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-615000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4746000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3624000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1391000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.062
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1142000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.066
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	115000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.005
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	43000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.002
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	569000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.025
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-274000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.016
CY2020	cvsi	Effective Income Tax Reconciliation Nondeductible Officer Compensation EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation	0	USD
CY2020	cvsi	Effective Income Tax Reconciliation Nondeductible Officer Compensation Percent EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent	0
CY2019	cvsi	Effective Income Tax Reconciliation Nondeductible Officer Compensation EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation	1242000	USD
CY2019	cvsi	Effective Income Tax Reconciliation Nondeductible Officer Compensation Percent EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent	-0.072
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	242000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.011
CY2019	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	320000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.019
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	769000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.036
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-241000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.014
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4609000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.204
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3701000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.215
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-317000	USD
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.013
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-615000	USD
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.036
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5876000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2627000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	918000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	620000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	756000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	890000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6470000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6740000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	61000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	268000	USD
CY2020Q4	cvsi	Deferred Tax Asset Operating Lease Liabilities DeferredTaxAssetOperatingLeaseLiabilities	1126000	USD
CY2019Q4	cvsi	Deferred Tax Asset Operating Lease Liabilities DeferredTaxAssetOperatingLeaseLiabilities	2866000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	2275000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	383000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17482000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	14394000	USD
CY2020Q4	cvsi	Deferred Tax Liability Operating Lease Assets DeferredTaxLiabilityOperatingLeaseAssets	830000	USD
CY2019Q4	cvsi	Deferred Tax Liability Operating Lease Assets DeferredTaxLiabilityOperatingLeaseAssets	2437000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	396000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	390000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	1013000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	1054000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	29000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	172000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2268000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4053000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15371000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	10762000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	157000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	421000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4600000	USD
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	3700000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	47000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	119000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	166000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD

Files In Submission

Name	View Source	Status
0001510964-21-000012-index-headers.html	Edgar Link	pending
0001510964-21-000012-index.html	Edgar Link	pending
0001510964-21-000012.txt	Edgar Link	pending
0001510964-21-000012-xbrl.zip	Edgar Link	pending
a302certificationceoex3112.htm	Edgar Link	pending
a302certificationcfoex3122.htm	Edgar Link	pending
a906certificationceoex3212.htm	Edgar Link	pending
a906certificationcfoex3222.htm	Edgar Link	pending
consentex231202010kng.htm	Edgar Link	pending
cvsi-20201231.htm	Edgar Link	pending
cvsi-20201231.xsd	Edgar Link	pending
cvsi-20201231_cal.xml	Edgar Link	unprocessable
cvsi-20201231_def.xml	Edgar Link	unprocessable
cvsi-20201231_htm.xml	Edgar Link	completed
cvsi-20201231_lab.xml	Edgar Link	unprocessable
cvsi-20201231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CVSI
CV Sciences, Inc. Stock $cvsi

2020 Q4 Form 10-K Financial Statement

#000151096421000012 Filed on March 19, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVSI CV Sciences, Inc. Stock $cvsi

2020 Q4 Form 10-K Financial Statement

#000151096421000012 Filed on March 19, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVSI
CV Sciences, Inc. Stock $cvsi